Interleukin-6 in clinical medicine

Joachim Bauer1, F Herrmann2
1Psychiatrische Universitätsklinik, Universität Freiburg, FRG.
2Psychiatrische Universitätsklinik und Medizinische Universitätsklinik (Abteilung Innere Medizin 1), Universität Freiburg, Freiburg, FRG

Tóm tắt

Từ khóa


Tài liệu tham khảo

Aarden LA, De Groot ER, Schaap OL, Lansdorp PM (1987) Production of hybridoma growth factor by human monocytes. Eur J Immunol 17: 1411–1416

Akira S, Hirano T, Taga T, Kishimoto T (1990) Biology of multifunctional cytokines: IL-6 and related molecules. FASEB J 4: 2860–2867

Andus T, Gross V, Cäsar J, Krumm D, Hosp J, David M, Schölmerich J (1991) Activation of monocytes during inflammatory bowel disease. Pathobiol (in press)

Asano S, Okano A, Ozawa K, Nakahata T, Ishibashi T, Koike K, Kimura H, Tanioka Y, Shibuya A, Hirano T, Kishimoto T, Takaku F, Akiyama Y (1990) In vivo effects of recombinant human interleukin-6 in primates: stimulated production of plate-lets. Blood 75: 1602–1605

Asaoku H, Kawano M, Iwato K, Tanabe O, Tanaka H, Hirano T, Kishimoto T, Kuramoto A (1988) Decrease in BSF-2/IL-6 response in advanced cases of multiple myeloma. Blood 72: 429–432

Bataille R, Jourdan M, Zhang XG, Klein B (1989) Serum levels of interleukin-6, a potent myeloma cell growth factor, as a reflection of disease severity in plasma cell dyscrasias. J Clin Invest 84: 2008–2010

Bauer J (1989) Interleukin-6 and its receptor during homeostasis, inflammation, and tumor growth. Klin Wochenschr 67: 697–706

Bauer J, Ganter U, Geiger T, Jacobshagen U, Hirano T, Matsuda T, Kishimoto T, Andus T, Acs G, Gerok W, Ciliberto G (1988) Regulation of interleukin-6 expression in cultured human blood monocytes and monocyte-derived macrophages. Blood 72: 1134–1140

Bauer J, Bauer TM, Kalb T, Taga T, Lengyel G, Hirano T, Kishimoto T, Acs G, Mayer L, Gerok W (1989) Regulation of interleukin-6 receptor expression in human monocytes and monocyte-derived macrophages. Comparison with the expression in human hepatocytes. J Exp Med 170: 1537–1549

Bender S, Haubeck HD, Van de Leur E, Dufhues G, Schiel X, Lauweriins J, Greiling H, Heinrich PC (1990) Interleukin-1 β induces synthesis and secreation of interleukin-6 in human chondrocytes. FEBS Lett 263: 321–324

Bhardwaj N, Santhanam U, Lau LL, Tatter SB, Ghrayeb J, Rivels M, Steinmann RM, Sehgal PB, May LT (1989) IL-6/IFNβ2 in synovial effusions of patients with rheumatoid arthritis and other arthritides. J Immunol 143: 2153–2159

Biondi A, Rossi V, Bassan R, Barbui T, Bettoni S, Sironi M, Mantovani A, Rambaldi A (1989) Constitutive expression of the interleukin-6 gene in chronic lymphocytic leukemia. Blood 73: 1279–1284

Bodine D, Karlsson S, Nienhuis AW (1989) Combination of interleukin-3 and -6 preserves stem cell function in culture and enhances retrovirus-mediated gene transfer into hemopoietic stem cells. Proc Natl Acad Sci USA 86: 8897–8901

Bot FJ, van Eijk L, Broeders L, Aarden LA, Löwenberg B (1989) Interleukin-6 synergizes with M-CSF in the formation of macrophage colonies from purified human marrow progenitor cells. Blood 73: 135–137

Brach MA, Löwenberg B, Mantovani L, Schwulera U, Brennscheidt U, Mertelsmann R, Herrmann F (1990) Interleukin-6 (IL-6) is an intermediate in IL-1-induced proliferation of leukemic human megakaryoblasts. Blood 76: 1972–1979

Brach MA, Cicco NA, Riedel D, Hirano T, Kishimoto T, Mertelsmann RH, Herrmann F (1990) Mechanisms of differential regulation of interleukin-6 mRNA accumulation by tumor necrosis factor alpha and lymphotoxin during monocytic differentiation. FEBS Lett 263: 349–354

Brandt SJ, Bodine DM, Dunbar CE, Nienhuis AW (1990) Dysregulated interleukin-6 expression produces a syndrome resembling Castleman's disease in mice. J Clin Invest 86: 592–599

Breen EC, Rezai AR, Nakajima K, Beall GN, Mitsuyasu RT, Hirano T, Kishimoto T, Martinez-Maza O (1990) Infection with HIV is associated with elevated IL-6 levels and production. J Immunol 144: 480–484

Broukaert P, Spriggs DR, Demetri G, Kufe DW, Fiers W (1989) Circulating interleukin-6 during a continuous infusion of tumor necrosis factor and interferon gamma. J Exp Med 169: 2257–2262

Caracciolo D, Clark SC, Rovera G (1989) Human interleukin-6 supports granulocyte differentiation of hematopoietic progenitor cells and acts synergistically with GM-CSF. Blood 73: 666–670

Chen L, Novick D, Rubinstein M, Revel M (1988) Recombinant interferon-β2 (interleukin-6) induces myeloid differentiation. FEBS Lett 239: 299–304

Chen L, Mory Y, Zilberstein A, Revel M (1988) Growth inhibition of human breast carcinoma and leukemia/lymphoma cell lines by recombinant interferon β2. Proc Natl Acad Sci USA 85: 8037–8041

Chiu CP, Lee F (1989) IL-6 is a differentiation factor for M1 and WEHI-3B myeloid leukemic cells. J Immunol 142: 1909–1915

Cicco NA, Lindemann A, Content J, Vandenbussche P, Lübbert M, Gauss J, Mertelsmann R, Herrmann F (1989) Inducible production of interleukin-6 by human polymorphonuclear neutrophils: role of granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-alpha. Blood 75: 2049–2052

Everson MP, Brown CB, Lilly MB (1989) Interleukin-6 and granulocyte-macrophage colony-stimulating factor are candidate growth factors for chronic myelomonocytic leukemia cells. Blood 74: 1472–1476

Fiedler W, Weh HJ, Sucin E, Wittlief C, Stocking C, Hossfeld DK (1990) The IL-6 gene but not the IL-6 receptor gene is occasionally rearranged in patients with multiple myeloma. Leukemia 4: 462–465

Fong Y, Moldawer LL, Marano M, Wei H, Tatter SB, Clarick RH, Santhanam U, Sherris D, May LT, Sehgal PB, Lowry SF (1989) Endotoxemia elicits increased circulating IFN-β2/IL-6 in man. J Immunol 142: 2321–2324

Freeman GJ, Freedman AS, Rabinowe SN, Segil JM, Horowitz J, Rosen K, Whitman JF, Nadler LM (1989) Interleukin-6 gene expression in normal and neoplastic B cells. J Clin Invest 83: 1512–1518

Frei K, Malipiero UV, Leist TP, Zinkernagel RM, Schwab ME, Fontana A (1989) On the cellular source and function of interleukin-6 in the central nervous system in viral disease. Eur J Immunol 19: 689–694

Ganter U, Arcone R, Toniatti C, Ciliberto G (1989) Dual control of CRP gene expression by interleukin-1 and interleukin-6. EMBO J 8: 3773–3779

Garman RD, Jacobs KA, Clark SC, Raulet DH (1987) B-cellstimulatory factor 2 (β2-interferon) functions as a second signal for interleukin-2 production by mature murine T cells. Proc Natl Acad Sci USA 84: 7629–7633

Grau GE (1990) Implications of cytokines in immunopathology: experimental and clinical data. Eur Cytokine Net 1: 203–210

Grossmann RM, Krueger J, Yourish D, Granelli-Piperno A, Murphy DP, May LT, Kupper TS, Sehgal PB, Gottlieb AB (1989) Interleukin-6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proc Natl Acad Sci USA 86: 6367–6371

Guerne PA, Carson DA, Lotz M (1990) IL-6 production by human articular chondrocytes. J Immunol 144: 499–505

Hack CE, De Groot ER, Felt-Bersma RJF, Nuijens JH, Van Schijndel RJM, Eerenberg-Belmer AJM, Thijs LG, Aarden LA (1989) Increased plasma levels of interleukin-6 in sepsis. Blood 74: 1704–1710

Helfgott DC, Tatter SB, Santhanam U, Clarick RH, Bhardwaj N, May LT, Sehgal PB (1989) Multiple forms of IFN-β2/IL-6 in serum and body fluids during acute bacterial infection. J Immunol 142: 948–953

Hibi M, Murakami M, Saito M, Hirano T, Taga T, Kishimoto T (1990) Molecular cloning and expression of an IL-6 signal transducer, gp 130. Cell 63: 1149–1157

Hill RJ, Warren MK, Levin J (1990) Stimulation of thrombopoiesis in mice by human recombinant interleukin-6. J Clin Invest 85: 1242–1247

Hirano T (1990) Interleukin-6 in immune response and hematopoiesis. In: Mertelsmann R, Herrmann F (eds) Hematopoietic growth factors in clinical applications. Marcel Dekker, New York, pp 471–488

Hirano T, Taga T, Nakano N, Yasukawa K, Kashiwamura S, Shimizu K, Nakajima K, Pyun KH, Kishimoto T (1985) Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSF-2). Proc Natl Acad Sci USA 82: 5490–5494

Hirano T, Taga T, Yasukawa K, Nakajima K, Nakano N, Takatsuki F, Shimizu M, Murashima A, Tsunasawa S, Sakiyama F, Kishimoto T (1987) Human B-cell differentiation factor defined by antipeptide antibody and its possible role in autoantibody production. Proc Natl Acad Sci USA 84: 228–231

Hirano T, Matsuda T, Turner M, Miyasaka N, Buchan G, Tang B, Sato K, Shimizu M, Maini R, Feldmann M, Kishimoto T (1988) Excessive production of interleukin-6/B-cell-stimulatory factor-2 in rheumatoid arthritis. Eur J Immunol 18: 1797–1801

Hoang T, Haman A, Goncalves O, Wong GG, Clark SC (1988) Interleukin-6 enhances growth factor-dependent proliferation of the blast cells of acute myeloblastic leukemia. Blood 72: 823–826

Horii Y, Muraguchi A, Iwano M, Matsuda T, Hirayama T, Yamada H, Fuji Y, Dohi K, Ishikawa H, Ohomoto Y, Yoshizaki K, Hirano T, Kishimoto T (1989) Involvement of IL-6 in mesangial proliferative glomerulonephritis. J Immunol 143: 3949–3955

Houssiau FA, Bukasa K, Sindic CJM, Van Damme J, Van Snick J (1988) Elevated levels of the 26-K human hybridoma growth factor (interleukin-6) in cerebrospinal fluid of patients with acute infection of the central nervous system. Clin Exp Immunol 71: 320–323

Houssiau FA, Coulie PG, Olive D, Van Snick J (1988) Synergistic activation of human T cells by interleukin-1 and interleukin-6. Eur J Immunol 18: 653–656

Ikebuchi K, Wong GG, Clark SC, Ihle JN, Hirai Y, Ogawa M (1987) Interleukin-6 enhancement of interleukin-3-dependent proliferation of multipotential hemopoietic progenitors. Proc Natl Acad Sci USA 84: 9035–9039

Ishibashi T (1989) Kimura H, Uchida T, Kariyone S, Friese P, Burstein SA (1989) Human interleukin-6 is a direct promoter of maturation of megakaryocytes in vitro. Proc Natl Acad Sci USA 86: 5953–5957

Ishibashi T, Kimura H, Shikama Y, Uchida T, Kariyone S, Hirano T, Kishimoto T, Takatsuki F, Akiyama Y (1989) Interleukin-6 is a potent thrombopoietic factor in vivo in mice. Blood 74: 1241–1244

Ishikawa H, Tanaka H, Iwato K, Tanabe O, Assaoku H, Nobuyoshi M, Yamamoto I, Kawano M, Kuramoto A (1990) Effect of glucocorticoids on the biological activities of myeloma cells: inhibition of interleukin-1β osteoclast activating factorinduced bone resorption. Blood 75: 715–720

Ishimi Y, Miyaura L, Jin C, Akatsu T, Abe E, Nakamura Y, Yamaguchi A, Yoshiki S, Matsuda T, Hirano T, Kishimoto T, Suda T (1990) IL-6 is produced by osteoblasts and induces bone resorption. J Immunol 145: 3297–3303

Jablons DM, Mule JJ, McIntosh JK, Sehgal PB, May LT, Huang CM, Rosenberg SA, Lotze MT (1989) IL-6/IFNβ2 as a circulating hormone. Induction by cytokine administration. J Immunol 142: 1542–1547

Jourdan M, Bataille R, Seguin J, Zhang XG, Chaptal PA, Klein B (1990) Constitutive production of interleukin-6 and immunologic features in cardiac myxoma. Arthritis Rheum 33: 398–403

Kato K, Yokoi T, Takano N, Kanegane H, Yachie A, Miyawaki T, Taniguchi N (1990) Detection by in situ hybridization and phenotypic characterization of cells expressing IL-6 mRNA in human stimulated blood. J Immunol 144: 1317–1322

Kawano M, Hirano T, Matsuda T, Taga T, Horii Y, Iwato K, Asaoku H, Tang B, Tanabe O, Tanaka H, Kuramoto A, Kishimoto T (1988) Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature 332: 83–85

Kirnbauer R, Köck A, Schwarz T, Urbanski A, Krutmann J, Borth W, Damm D, Shipley G, Ansel JC, Luger TA (1989) IFNβ2, BSF-2, or hybridoma growth factor (IL-6) is expressed and released by human epidermal cells and epidermoid carcinoma cell lines. J Immunol 142: 1922–1928

Kishimoto T (1989) The biology of interleukin-6. Blood 74: 1–10

Klein B, Zhang XG, Jourdan M, Content J, Houssian F, Aarden L, Piechaczyk M, Bataille R (1989) Paracrine rather than autocrine regulation of myeloma — cell growth and differentiation by IL-6. Blood 73: 517–526

Klein B, Zhang XG, Jourdan M, Boiron JM, Portier M, Lu ZY, Wijdenes J, Brochier J, Bataille R (1990) Interleukin-6 is the central tumor growth factor in vitro and in vivo in multiple myeloma. Eur Cytokine Net 1: 193–201

Klein H, Becher R, Lübbert M, Oster W, Schleiermacher E, Brach MA, Souza L, Lindemann A, Mertelsmann R, Herrmann F (1990) Synthesis of granulocyte colony-stimulating factor and its requirement for terminal divisions in chronic myelogenous leukemia. J Exp Med 171: 1785–1790

Koike K, Nakahata T, Kikuchi T, Takagi M, Ishiguro A, Tsuji K, Naganuma K, Okano A, Akiyama T (1990) Interleukin-6 enhances murine megakaryocytopoiesis in serum-free culture. Blood 75: 2286–2291

Krutman J, Elmets CA (1988) Recent studies on mechanisms in photoimmunology. Photochem Photobiol 48: 787–798

Kurihara N, Bertolini D, Suda T, Akiyama Y, Roodman GD (1990) IL-6 stimulates osteoclast-like multinucleated cell formation in long-term human marrow cultures by inducing IL-1 release. J Immunol 144: 4226–4230

Lansdorp PM, Aarden LA, Calafat J, Zeiljemaker WP (1986) A growth-factor-dependent B-cell hybridoma. Curr Top Microbiol Immunol 132: 105–113

Lee JD, Swisher SG, Minehart EH, Mc Bride WH, Economou JS (1990) Interleukin-4 down regulates interleukin-6 production in human peripheral blood mononuclear cells. J Leuk Biol 47: 475–479

Leary AG, Ikebuchi K, Hirai Y, Wong GG, Yang YC, Clark SC, Ogawa M (1988) Synergism between interleukin-6 and interleukin-3 in supporting proliferation of human hematopoietic stem cells: comparison with interleukin-1 alpha. Blood 71: 1759–1763

Lindemann A, Ganser A, Hoelzer D, Mertelsmann R, Herrmann F (1991) In vivo administration of recombinant human interleukin-3 elicits an acute phase response involving endogenous synthesis of interleukin-6. Ann Intern Med (in press)

Loppnow H, Libby P (1990) Proliferating or interleukin-1-activated human vascular smooth muscle cells screte copious interleukin-6. J Clin Invest 85: 731–738

Lotem J, Shabo Y, Sachs L (1989) Regulation of megakaryocyte development by interleukin-6. Blood 74: 1545–1551

Lorre K, Van Damme J, Verwilghen J, Baroja ML, Ceuppens JL (1990) IL-6 is an accessory signal in the alternative CD2-mediated pathway of T-cell activation. J Immunol 144: 4681–4687

Lübbert M, Oster W, McComick F, Mertelsmann R, Herrmann F (1991) Clonal analysis of N-ras gene activation in acute myeloid leukemia. J Clin Invest (in press)

Lübbert M, Brach M, Mertelsmann R, Herrmann F (1991) Interleukin-6 inhibits growth of plasma cell neoplasms due to suppression of endogenous interleukin-6. Blood (in press)

Luger TA, Schwarz T, Krutmann J, Kirnbauer R, Neuner P, Kock A, Urbanski A, Borth W, Schauer E (1989) Interleukin-6 is produced by epidermal cells and plays an important role in the activation of human T-lymphocytes and natural killer cells: regulation of the acute phase and immune responses. Ann NY Acad Sci 557: 405–414

Luger TA, Krutman J, Kirnbauer R, Urbanski A, Schwarz T, Klappacher G, Köck A, Micksche M, Malejczyk J, Schauer E, May LT, Sehgal PB (1989) IFNβ2/IL-6 augments the activity of human natural killer cells. J Immunol 143: 1206–1209

Mantovani L, Henschler R, Brach MA, Wieser R, Lübbert M, Lindemann A, Mertelsmann R, Herrmann F (1990) Differential regulation of interleukin-6 expression in human fibroblasts by tumor necrosis factor-alpha and lymphotoxin. FEBS Lett 270: 152–156

Matsuda T, Hirano T, Kishimoto T (1988) Establishment of a interleukin-6 dependent cell line and preparation of anti-IL-6 monoclonal antibodies. Eur J Immunol 18: 951–956

Miki S, Iwano M, Miki Y, Yamamoto M, Tang B, Yokokawa K, Sonoda T, Hirano T, Kishimoto T (1989) Interleukin-6 (IL-6) functions as an in vitro autocrine growth factor in renal carcinomas. FEBS Lett 250: 607–610

Miles SA, Rezai AR, Salazar-Gonzales JF, Van der Meyden M, Stevens RH, Logan DM, Mitsuyasu RT, Taga T, Hirano T, Kishimoto T, Martinez-Maza O (1990) AIDS Kaposi sarcomaderived cells produce and respond to interleukin-6. Proc Natl Acad Sci USA 87: 4068–4072

Morinaga Y, Suzuki H, Takatsuki F, Akiyama Y, Taniyama T, Matsushima K, Onozaki K (1989) Contribution of IL-6 to the antiproliferative effect of IL-1 and tumor necrosis factor on tumor cell lines. J Immunol 143: 3538–3542

Moshage HJ, Roelofs HNJ, Van Pelt JF, Hazenberg BPC, Van Leewen MA, Limburg PC, Aarden LA, Yap SH (1988) The effect of interleukin-1, interleukin-6 and its interrelationship on the synthesis of serum amyloid A and C-reactive protein in primary cultures of adult human hepatocytes. Biochem Biophys Res Comm 155: 112–117

Mule JJ, McIntosh JK, Jablons DM, Rosenberg SA (1990) Antitumor activity of recombinant interleukin-6 in mice. J Exp Med 171: 629–636

Musso T, Espinoza-Delgado J, Pulkki K, Gussela GL, Longo DL, Varesio L (1990) Transforming growth factor beta downregulates interleukin-1-induced IL-6 production by human monocytes. Blood 76: 2466–2469

Nagasawa T, Orita T, Matsushita J, Tsuchiya M, Neichi T, Imazeki I, Imai N, Ochi N, Kanma H, Abe T (1990) Thrombopoietic activity of human interleukin-6. FEBS Lett 260: 176–178

Nijsten MWN, De Groot ER, Ten Duis HJ, Klasen HJ, Hack CE, Aarden LA (1987) Serum levels of interleukin-6 and acute phase responses. Lancet 2: 921

Oster W, Cicco NA, Klein H, Hirano T, Kishimoto T, Lindemann A, Mertelsmann R, Herrmann F (1989) Participation of the cytokines interleukin-6, tumor necrosis factor-alpha, and interleukin-1-beta secreted by acute myelogenous leukemia blasts in autocrine and paracrine leukemia growth control. J Clin Invest 84: 451–457

Poli G, Bressler P, Kinter T, Duh E, Timmer WC, Rabson A, Justement S, Stanley S, Fauci AS (1990) Interleukin-6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and posttranscriptional mechanisms. J Exp Med 172: 151–158

Pullicino EA, Carli F, Poole S, Rafferty B, Malik STA, Elia M (1990) The relationship between the circulating concentrations of interleukin-6 (IL-6), tumor necrosis factor (TNF) and the acute phase response to elective surgery and accidental injury. Lymphok Res 9: 2–6

Rennick D, Jackson J, Yang G, Wideman J, Lee F, Hudak S (1989) Interleukin-6 interacts with interleukin-4 and other hematopoietic growth factors to selectively enhance the growth of megakaryocytic, erythoid, myeloid and multipotential progenitor cells. Blood 73: 1828–1835

Revel M, Chen L, Novivk D, Shulman LM, Gotthelf Y, Cohen B, Raber J, Chebath J, Michaelevicz R (1990) The growthpromoting, differentiative and cytostatic properties of interleukin-6. Proc Am Assoc Canc Res 31: 499–505

Romero R, Avila C, Santhanam U, Sehgal PB (1990) Amniotic fluid interleukin-6 in preterm labor. J Clin Invest 85: 1392–1400

Rose-John S, Schooltink H, Lenz D, Hipp E, Dufhues G, Schmitz H, Schiel X, Hirano T, Kishimoto T, Heinrich PC (1990) Studies on the structure and regulation of the human hepatic interleukin-6 receptor. Eur J Biochem 190: 79–83

Sachs L, Lotem J, Shabo Y (1989) The molecular regulators of macrophage and granulocyte development. Ann NY Acad Sci 557: 417–437

Shabo Y, Lotem J, Sachs L (1989) Autoregulation of interleukin-6 and granulocyte-macrophage colony-stimulating factor in the differentiation of myeloid leukemia cells. Mol Cell Biol 9: 4109–4112

Shenkin A, Fraser WD, Series J, Winstanley FP, McCartney AC, Burns HJG, Van Damme J (1989) The serum interleukin-6 response to elective surgery. Lymphok Res 8: 123–127

Siegall CB, Chaudhary VK, Fitzgerald DJ, Pastan I (1988) Cytotoxic activity of an interleukin-6-Pseudomonas exotoxin fusion protein on human myeloma cells. Proc Natl Acad Sci USA 85: 9738–9742

Sironi M, Breviario F, Proserpio P, Biondi A, Vecchi J, Van Damma E, Mantovani A (1989) IL-1 stimulates IL-6 production in endothelial cells. J Immunol 142: 549–553

Smyth MJ, Ortaldo JR, Bere W, Yagita H, Okumura K, Young HA (1990) IL-2 and IL-6 synergize to augment the pore-forming protein gene expression and cytotoxic potential of human peripheral blood T cells. J Immunol 145: 1159–1166

Suzuki C, Okano A, Takatsuki F, Miyasaka Y, Hirano T, Kishimoto T, Ejima D, Akiyama Y (1989) Continuous perfusion with interleukin-6 enhances production of hematopoietic stem cells (CFU-S). Biochem Biophys Res Commun 159: 933–938

Bender S, Haubeck HD, Van de Leur E, Dufhues G, Schiel X, Lauweriins J, Greiling H, Heinrich PC (1990) Interleukin-1 β induces synthesis and secreation of interleukin-6 in human chondrocytes. FEBS Lett 263: 321–324

Tabibzadeh SS, Poubouridis D, May LT, Sehgal PB (1991) Interleukin-6 immunoreactivity in human tumors. Am J -Pathol (in press)

Tamm I, Cardinale I, Krueger J, Murphy JS, May LT, Sehgal PB (1989) Interleukin-6 decreases cell-cell association and increases motility of ductal breast carcinoma. J Exp Med 170: 1649–1669

Te Velde AA, Huijbens RJF, Heije K, des Vries JE, Figdor CG (1990) Interleukin-4 (IL-4) inhibits secretion of IL-1β, tumor necrosis factor-alpha and IL-6 by monocytes. Blood 76: 1392–1397

Tosato G, Miller J, Marti G, Pike SE (1990) Accessory function of interleukin-1 and interleukin-6: preferential costimulation of T4-positive lymphocytes. Blood 75: 922–930

Utsumi K, Takai Y, Tada T, Ohzeki S, Fujiwara H, Hamaoka T (1990) Enhanced production of IL-6 in tumor-bearing mice and determination of cells responsible for its augmented production. J Immunol 145: 397–403

van der Schoot CE, Jansen P, Poorter M, Wester MR, Kr. von dem Borne AEG, Aarden LA, von Oers RHJ (1989) Interleukin-6 and interleukin-1 production in acute myeloid leukemia with monocytoid differentiation. Blood 74: 2081–2087

van Oers MHJ, van der Heyden AAPAM, Aarden LA (1988) Interleukin-6 (IL-6) in serum and urine of renal transplant recipients. Clin Exp Immunol 71: 314–319

van Snick J, Cayphas S, Vink A, Uyttenhove C, Coulie PG, Rubira MR, Simpson RJ (1986) Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas. Proc Natl Acad Sci USA 83: 9679–9684

Yasukawa K, Hirano T, Watanabe Y, Murutoni K, Matsuda T, Nakai S, Kishimoto T (1987) Structure and expression of human B-cell stimulatory factor-2 (BSF-2/IL-6) gene. EMBO J 6: 2939–2945

Yoshizaki K, Nakagawa T, Fukunaga K, Tseng LT, Yamamura Y, Kishimoto T (1984) Isolation and characterization of B-cell differentiation factor (BCDF) secreted from a human B lymphoblastoid cell line. J Immunol 132: 2948–2954

Yoshizaki K, Matsuda T, Nishimoto N, Kuritani T, Taeho L, Aozasa K, Nakahate T, Kawai H, Tagoh H, Komori T, Kishimoto S, Hirano T, Kishimoto S (1989) Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. Blood 74: 1360–1367

Zhang XG, Klein B, Bataille R (1989) Interleukin-6 is a potent myeloma-cell growth factor in patients with aggressive multiple myeloma. Blood 74: 11–13